Periodontal Disease Treatment Market Report 2026

The periodontal disease treatment market size has grown strongly in recent years. It will grow from $1.67 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to high prevalence of gingivitis and periodontitis, limited awareness of periodontal disease treatments, reliance on conventional dental care methods, inadequate early diagnostic tools, fragmented dental care delivery systems.

The periodontal disease treatment market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to advancements in minimally invasive surgical procedures, growing adoption of regenerative therapy and bone grafts, expansion of dental clinics and academic research institutes, rising patient awareness and demand for periodontal care, integration of digital solutions and connected oral care systems. Major trends in the forecast period include increasing use of ai for early diagnosis and risk stratification, rising adoption of digital and cloud-based patient records, growing use of iot-enabled devices for post-treatment monitoring, increasing implementation of smart manufacturing for periodontal instruments, rising focus on personalized periodontal therapy based on genomic insights.

The increasing incidence of oral health disorders is expected to drive the growth of the periodontal disease treatment market in the coming years. Oral health disorders include conditions affecting the teeth, gums, and oral cavity, such as dental caries, gum diseases, oral infections, and oral cancer. The growing burden of these disorders is attributed to factors including poor oral hygiene practices, unhealthy dietary habits, tobacco and alcohol consumption, aging populations, and limited access to dental care services. Periodontal disease treatment plays a vital role in managing and preventing oral health disorders by addressing gum infections, inflammation, and associated bone loss. For instance, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental public health organization, oral diseases were estimated to affect nearly 3.7 billion people worldwide. Therefore, the rising prevalence of oral health disorders is contributing to the growth of the periodontal disease treatment market.

Major companies operating in the periodontal disease treatment market are focusing on the development of innovative solutions such as dental gels to enhance bone regeneration, improve accessibility to treatment, reduce procedural invasiveness, and provide more effective and patient-friendly alternatives to conventional periodontal therapies. Dental gels are medicated oral formulations containing antibacterial, anti-inflammatory, or fluoride components that help prevent cavities, reduce gum disease, and alleviate oral discomfort. For example, in October 2024, Oral Biolife Inc., a US-based biotechnology company, announced the development of Ambrilux Dental Gel, an advanced treatment aimed at promoting bone regeneration in periodontal disease. The product demonstrated promising outcomes in large animal trials, with studies in Beagle dogs showing increased bone growth in all treated subjects. This innovation has the potential to transform non-invasive periodontal care for both humans and companion animals by addressing a significant unmet medical need.

In March 2023, Intermed Inc., a US-based healthcare technology management company, acquired Perio Protect for an undisclosed amount. Through this acquisition, Intermed sought to expand its dental care portfolio by incorporating Perio Protect’s periodontal tray treatment technology. This move strengthens Intermed’s market position, enhances its ability to deliver comprehensive dental solutions ranging from prevention to restoration, and creates new growth opportunities across the United States and Canadian markets. Perio Protect is a US-based medical equipment manufacturer specializing in the design and production of custom trays for periodontal disease treatment.

Major companies operating in the periodontal disease treatment market are Bausch Health Companies Inc, DENTSPLY SIRONA Inc., Straumann AG, Sunstar Suisse S.A, NovaBone Products LLC, Nakanishi Inc., Brasseler USA, Geistlich Pharma AG, BIOLASE Inc., Bien-Air Dental, Convergent Dental Inc., Carl Martin GmbH, Karl Schumacher, Yoshida Dental MFG. Co. Ltd., Botiss Biomaterials GmbH, Millennium Dental Technologies Inc., PreXion Inc., AMD Lasers Inc., Steris Healthcare Pvt Ltd, Perio Protect, Deppeler SA.

North America was the largest region in the periodontal disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the periodontal disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the periodontal disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the periodontal disease treatment market by increasing costs of imported diagnostic, treatment, and surgical instruments, particularly affecting hospitals, dental clinics, and research institutes in North America and Europe. While adoption has been temporarily slowed due to higher costs, these tariffs have also encouraged domestic manufacturing, promoted innovation in cost-effective treatment solutions, and improved overall supply chain resilience.

The periodontal disease treatment market research report is one of a series of new reports that provides periodontal disease treatment market statistics, including periodontal disease treatment industry global market size, regional shares, competitors with a periodontal disease treatment market share, detailed periodontal disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the periodontal disease treatment industry. This periodontal disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Periodontal disease treatment involves medical procedures and therapeutic interventions designed to prevent, control, and reverse the progression of periodontal diseases that affect the gums and the supporting structures of the teeth. The primary goals of treatment are to reduce inflammation, prevent tooth loss, and enhance overall oral health.

The main categories of periodontal disease treatment include gingivitis, chronic periodontal disease, aggressive periodontal disease, and other forms. Gingivitis is characterized by inflammation, redness, and swelling of the gums resulting from plaque accumulation around the teeth. Treatment approaches include non-surgical therapies, scaling and root planing, medication, and surgical options such as flap surgery and bone grafting, along with other procedures. These treatments are delivered through routes such as oral and injectable administration and are distributed via channels including hospital pharmacies, retail pharmacies, and others. They are used by a range of end users, including hospitals, clinics, dental clinics, dental academic institutions, and research institutes, among others.

The periodontal disease treatment market consists of revenues earned by entities by providing services such as professional dental cleanings, scaling and root planing, antibiotic therapy, surgical interventions for severe cases, laser therapy for gum restoration, and ongoing maintenance to prevent disease progression. The market value includes the value of related goods sold by the service provider or included within the service offering. The periodontal disease treatment market also includes sales of antiseptic mouthwashes, scaling and root planing kits, laser therapy devices, and diagnostic tools & devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.